Barney Bishop
31Patents
16h-index
28Co-inventors
77Inventor score
Filing activity: Jun 1, 2004 → Aug 4, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7105486B2 | Abuse-resistant amphetamine compounds | Human Necessities | 83 | Expired |
| US7678770B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 55 | Active |
| US7671030B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 54 | Active |
| US7223735B2 | Abuse resistant lysine amphetamine compounds | Emerging Cross-Sectional Technologies | 48 | Expired |
| US7655630B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 45 | Active |
| US7662787B2 | Abuse resistant lysine amphetamine compounds | Emerging Cross-Sectional Technologies | 43 | Active |
| US7659253B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 42 | Active |
| US7700561B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 40 | Active |
| US7674774B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7718619B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7687466B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7671031B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7723305B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7678771B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7659254B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 38 | Active |
| US7687467B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 25 | Active |
| US7662788B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 16 | Active |
| US7713936B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 16 | Active |
| US8133881B2 | Carbohydrate conjugates to prevent abuse of controlled substances | Human Necessities | 8 | Active |
| US7438900B2 | Dendritic encapsulation of active agents | Performing Operations; Transporting | 6 | Expired |
| US9383299B2 | Method for harvesting nanoparticles and sequestering biomarkers | Emerging Cross-Sectional Technologies | 4 | Active |
| US8382987B2 | Method for harvesting nanoparticles and sequestering biomarkers | Emerging Cross-Sectional Technologies | 4 | Active |
| US8404636B2 | Targeted delivery of antimicrobial agents | Human Necessities | 3 | Active |
| US10174081B2 | Antimicrobial peptides and uses therefore | Human Necessities | 2 | Active |
| US10633420B2 | Antimicrobial peptides with wound healing activity | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.